ReviewCancer drug resistance (Alhambra, Calif.)2020

Biomarkers of resistance to immune checkpoint inhibitors in non-small-cell lung cancer: myth or reality?

Ivan Pourmir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.